David R. Tortolani - Concepedia

Author

David R. Tortolani

Bristol-Myers Squibb (United States)

Also Known As

D. R. TORTOLANI, David R Tortolani, David R. Tortolani, David Tortolani

Publications

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Inserm Institut de génétique et de biologie moléculaire et cellulaire Centre National de la Recherche Scientifique

About

David R. Tortolani is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	551
2	Natural Sciences	6	6	319
3	Biochemistry	4	4	284
4	Engineering	3	3	135
5	Biomolecular Engineering	3	3	116

David R. Tortolani

Publications

938

Citations

H-Index

Page 1

	Year	Citations
Two distinct actions of retinoid-receptor ligands Jiayang Chen, John L. Clifford, C. Zusi, Nature Signal TransductionRetinaFunctional SelectivityMedicineRetinoid-receptor Ligands	1996	196
Synthesis, Oral Bioavailability Determination, and in vitro Evaluation of Prodrugs of the Antiviral Agent 9-[2-(Phosphonomethoxy)ethyl]adenine (PMEA) John E. Starrett, David R. Tortolani, Michael J. M. Hitchcock, Journal of Medicinal Chemistry	1994	141
Synthesis and in vitro evaluation of a phosphonate prodrug: bis(pivaloyloxymethyl) 9-(2-phosphonylmethoxyethyl)adenine John E. Starrett, David R. Tortolani, Michael J. M. Hitchcock, Antiviral Research Medicinal ChemistryPharmaceutical ScienceBiochemistryNatural SciencesMedicine	1992	120
Preparation of 1-(2,3-dideoxy-.beta.-D-glycero-pent-2-enofuranosyl)thymine (d4T) and 2',3'-dideoxyadenosine (ddA): general methods for the synthesis of 2',3'-olefinic and 2',3'-dideoxy nucleoside analogs active against HIV Muzammil M. Mansuri, John E. Starrett, John A. Wos, The Journal of Organic Chemistry 2',3'-Dideoxy Nucleoside AnalogsBioorganic ChemistryAltmetric Attention ScoreOrganic ChemistryAntiviral Drug	1989	92
Rational design of RAR‐selective ligands revealed by RARβ crystal stucture Pierre Germain, Sabrina Kammerer, Efrén Pérez‐Santín, EMBO Reports Crystal StructureEngineeringRational DesignChemistryCrystallography	2004	86
Retinoic Acid Receptor β,γ-Selective Ligands: Synthesis and Biological Activity of 6-Substituted 2-Naphthoic Acid Retinoids Kuo‐Long Yu, Patrick Spinazze, Jacek Ostrowski, Journal of Medicinal Chemistry Biological ActivityMedicinal Chemistryγ-Selective LigandsBiochemistryRetinoic Acid Receptor	1996	56
Small Molecule Antagonist of Leukocyte Function Associated Antigen-1 (LFA-1): Structure−Activity Relationships Leading to the Identification of 6-((5<i>S</i>,9<i>R</i>)-9-(4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)nicotinic Acid (BMS-688521) Scott H. Watterson, Zili Xiao, Dharmpal S. Dodd, Journal of Medicinal Chemistry	2010	43
Discovery and Preclinical Pharmacology of an Oral Bromodomain and Extra-Terminal (BET) Inhibitor Using Scaffold-Hopping and Structure-Guided Drug Design Ashvinikumar V. Gavai, Derek Norris, George V. Delucca, Journal of Medicinal Chemistry	2021	40
A solid phase synthesis of miconazole analogs via an iodoetherification reaction David R. Tortolani, Scott A. Biller Tetrahedron Letters Experimental SynthesisChemical EngineeringEngineeringMiconazole AnalogsOrganic Chemistry	1996	32
Inhibition of disease progression by a novel retinoid antagonist in animal models of arthritis. Blake C. Beehler, Yong-Jiang Hei, Simon Chen, PubMed	2003	28

Page 1